Register entry
Chiesi USA, Inc.
- Registered sites
- 1
- Drug products
- 25
- Live patents
- 46
- Countries
- 1
- Base
- Italy
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Chiesi Farmaceutici S.p.A. | ParmaItaly | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002806655 |
Exclusivity
Patents
46Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Apr 2027 |
| CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Dec 2027 |
| CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Apr 2027 |
| CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Dec 2027 |
| CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Apr 2027 |
| CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Dec 2027 |
| CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Apr 2027 |
| CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | NICARDIPINE HYDROCHLORIDE | Dec 2027 |
| CLEVIPREX | CLEVIDIPINE | Oct 2031 |
| FERRIPROX | DEFERIPRONE | Oct 2029 |
| FERRIPROX | DEFERIPRONE | Oct 2038 |
| KENGREAL | CANGRELOR | May 2029 |
| KENGREAL | CANGRELOR | Nov 2030 |
| KENGREAL | CANGRELOR | Mar 2033 |
| KENGREAL | CANGRELOR | Jul 2035 |
Catalogue
Marketed products
25Showing 25 of 25.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| BETHKIS | tobramycin | SOLUTION | NDA |
| Cleviprex | clevipidine | EMULSION | NDA |
| Cleviprex | clevipidine | EMULSION | NDA |
| Curosurf | poractant alfa | SUSPENSION | BLA |
| ELFABRIO | pegunigalsidase alfa | INJECTION, SOLUTION, CONCENTRATE | BLA |
| ELFABRIO | pegunigalsidase alfa | INJECTION, SOLUTION, CONCENTRATE | BLA |
| FERRIPROX | deferiprone | SOLUTION | NDA |
| FERRIPROX | DEFERIPRONE | TABLET, FILM COATED | NDA |
| FERRIPROX | deferiprone | TABLET | NDA |
| FILSUVEZ | birch triterpenes | GEL | NDA |
| Juxtapid | lomitapide mesylate | CAPSULE | NDA |
| Juxtapid | lomitapide mesylate | CAPSULE | NDA |
| Juxtapid | lomitapide mesylate | CAPSULE | NDA |
| Juxtapid | lomitapide mesylate | CAPSULE | NDA |
| Juxtapid | lomitapide mesylate | CAPSULE | NDA |
| KENGREAL | cangrelor | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Lamzede | Velmanase alfa-tycv | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| Myalept | metreleptin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| Mycapssa | Octreotide | CAPSULE, DELAYED RELEASE | NDA |
| Revcovi | elapegademase-lvlr | INJECTION | BLA |
| Trimbow | beclomethasone dipropionate/formoterol fumarate/glycopyrrolate | AEROSOL, METERED | NDA |
| Trimbow | beclomethasone dipropionate/formoterol fumarate/glycopyrrolate | AEROSOL, METERED | NDA |
| Trimbow | beclomethasone dipropionate/formoterol fumarate/glycopyrrolate | AEROSOL, METERED | NDA |
| Trimbow | beclomethasone dipropionate/formoterol fumarate/glycopyrrolate | AEROSOL, METERED | NDA |
| ZYFLO | zileuton | TABLET | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.